$CBIS - Cannabis Science - To support its existing CBN patent, the company has delivered pure CBN compound to two research facilities in Europe where testing will be started to establish activity of CBN alone and in combination with other cannabinoids in anxiety, sleep disorders as well as in variety of neurological conditions including Alzheimer's disease. http://www.stockwatch.com/News/Item.aspx?bid=U-prLA33628-U%3aCBIS-20140522&symbol=CBIS®ion=U
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.